Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» IsoRay Acquires Exclusive Worldwide License for Liquid Iodine Iotrex® for GliaSite® Brain Cancer Treatment
IsoRay Acquires Exclusive Worldwide License for Liquid Iodine Iotrex® for GliaSite® Brain Cancer Treatment
IsoRay Acquires Exclusive Worldwide License for Liquid Iodine Iotrex® for GliaSite® Brain Cancer Treatment
Submitted by
moderatorj
on June 7, 2011 - 10:31pm
Source:
Yahoo/BusinessWire
News Tags:
cancer
brain cancer
IsoRay
license
Headline:
IsoRay Acquires Exclusive Worldwide License for Liquid Iodine Iotrex® for GliaSite® Brain Cancer Treatment
Do Not Allow Advertisers to Use My Personal information
